Page last updated: 2024-09-02

procyanidin and 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one

procyanidin has been researched along with 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one in 1 studies

Compound Research Comparison

Studies
(procyanidin)
Trials
(procyanidin)
Recent Studies (post-2010)
(procyanidin)
Studies
(5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one)
Trials
(5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one)
Recent Studies (post-2010) (5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one)
4,1161362,7471820145

Protein Interaction Comparison

ProteinTaxonomyprocyanidin (IC50)5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one (IC50)
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)1.48

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amiel, A; Bourdy, G; Chassagne, F; Deharo, E; Haddad, M; Manithip, C; Marti, G; Phakeovilay, C1

Other Studies

1 other study(ies) available for procyanidin and 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one

ArticleYear
A metabolomic approach to identify anti-hepatocarcinogenic compounds from plants used traditionally in the treatment of liver diseases.
    Fitoterapia, 2018, Volume: 127

    Topics: Andrographis; Antineoplastic Agents, Phytogenic; Apigenin; Apocynaceae; Asia, Southeastern; Biflavonoids; Bignoniaceae; Catechin; Diterpenes; Ethnopharmacology; Flavanones; Flavonoids; Hep G2 Cells; Humans; Lamiaceae; Liver Neoplasms; Metabolomics; Plants, Medicinal; Proanthocyanidins

2018